Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.

Am J Respir Crit Care Med · 2020 · PMC7301738 · PMID 32162970

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The endpoint did not reach statistical significance in the study, although that may be because that study was powered assuming a 30% reduction in mortality in a much milder patient population.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.